For laboratory research use only — not for human or veterinary use. Not evaluated by the U.S. FDA.
Neuropeptide
SELANK
A synthetic heptapeptide derived from tuftsin, examined in research for anxiolytic and cognitive-related effects tied to GABA and BDNF pathways.
Quantity
$29.99
Bundle & save
Delivery
Order by 3:00 PM ET for same-day dispatch
Cutoff 3:00 PM ET · same-day dispatch
Estimated arrival in 2–3 business days
Overnight shipping available
Free shipment protection included
SELANK
1 × 10mg · $29.99
99% purity, QC passed
HPLC + mass-spec verified
Shipment protection
Free on every order
Free shipping over $150
Same-day dispatch before 3PM ET
Certificate of Analysis
Third-party tested · Independent analytical lab
10mg
99.16%latest
| Tested | Measured | Purity |
|---|---|---|
| Jul 2026 | 10.55mg | 99.16% |
| May 2026 | 12.71mg | 99.80% |
| May 2026 | 13.12mg | 99.44% |
| Apr 2026 | 12.52mg | 99.89% |
| Feb 2026 | 13.00mg | 99.80% |
| Jan 2026 | 13.04mg | 99.67% |
| Dec 2025 | 14.41mg | 99.91% |
| Nov 2025 | 12.91mg | 99.72% |
Frequently researched together
Commonly studied alongside SELANK.
Compound information
Technical specifications
Molecular profile
| Type | Synthetic heptapeptide |
| CAS number | 129954-34-3 |
| Molecular weight | 751.9 g/mol |
| Amino acids | 7 |
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Formula | C33H57N11O9 |
Storage & stability
- ❄️
Lyophilized (powder)
-20°C · stable 2+ years
- ❄️
Reconstituted
2–8°C · use within 30 days
Sources & references
Peer-reviewed literature, for research context
- Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia
2008·PMID: 18454096Zozulia AA, Neznamov GG, Siuniakov TS, et al.
View source - Behavioural Neurology
Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats
2017·DOI: 10.1155/2017/5091027·PMID: 28280289Kasian A, Kolomin T, Andreeva L, et al.
View source - Frontiers in Pharmacology
Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission
2016·DOI: 10.3389/fphar.2016.00031·PMID: 26924987Volkova A, Shadrina M, Kolomin T, et al.
View source - Bulletin of Experimental Biology and Medicine
Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats
2019·PMID: 31625062Kozlovskii II, Andreeva LA, Myasoedov NF
View source - Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders
2014·PMID: 25176261Medvedev VE, Tereshchenko ON, Israelian AIu, et al.
View source - Bulletin of Experimental Biology and Medicine
The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity
2001·PMID: 11550013Zozulya AA, Kost NV, Yu Sokolov O, et al.
View source - Bulletin of Experimental Biology and Medicine
The Influence of Selank on the Level of Cytokines Under Conditions of Experimental Immunodeficiency
2020·PMID: 32621722View source
Important research notice
Not for human consumption. This product is sold exclusively for laboratory and in vitro research. It is not intended to diagnose, treat, cure, or prevent any disease.
Any research findings referenced on this page are drawn from published, peer-reviewed literature and are provided for educational context only. They are not product claims and should not be read as medical advice.
By purchasing, you confirm you are a qualified researcher and will handle this material in accordance with all applicable laws and institutional guidelines.